Results 21 to 30 of about 114,570 (194)
Implementation of soluble CD38 in blood crossmatching for patients on anti-CD38 therapy: A single-center experience. [PDF]
Abstract Background Human monoclonal (MoAb) anti‐CD38 antibodies, such as daratumumab, are used to treat diseases such as multiple myeloma. Because red blood cells (RBCs) express CD38, these MoAbs interfere with antibody screening and crossmatching in blood banks.
Javanbakht A +3 more
europepmc +2 more sources
Evaluation of point-of-care versus laboratory antiglobulin-enhanced major crossmatch testing in cats. [PDF]
Objectives It is recommended that all cats, regardless of transfusion history, undergo major crossmatch prior to blood product administration to decrease the likelihood of immunological transfusion reactions. A reliable and user‐friendly point‐of‐care crossmatch test would help make crossmatch testing more accessible.
Blois SL, Collier AJ, Sanz S, Chun I.
europepmc +2 more sources
BACKGROUND: The aim of pretransfusion testing (PTT) is to prevent the immune-mediated hemolytic reaction by the transfusion of incompatible donor red cells.
K Devi Anu +2 more
doaj +1 more source
Incompatible crossmatch: First sign of a hemolytic transfusion reaction due to out-of-group platelet transfusion. [PDF]
Platelet (PLT) transfusion is undertaken in a variety of clinical settings with thrombocytopenia, with or without bleeding. Since PLTs are most often stored in donor plasma, group-specific PLT transfusions are preferred to out-of-group transfusions. PLTs adsorb ABO antigens over their surface from the plasma. In major ABO-incompatible PLT transfusions,
Basu D +5 more
europepmc +3 more sources
Practical Solutions for Problems in Blood Grouping and Crossmatching
Hematologists often encounter transfusion problems, one of which is crossmatch incompatibility. In many countries, transfusion medicine is not a recognized specialty, there are no reference immunohematology laboratories, and most blood banks can only ...
Neslihan Andıç
doaj +1 more source
Sixty six patients were evaluated for donor specific anti HLA sensitization before they received ABO incompatible kidney transplantation. Each recipient was evaluated by complement dependent cytotoxicity (CDC) crossmatch, flow cytometric crossmatch ...
Sonia Mehrotra +6 more
doaj +1 more source
For patients with end stage renal disease, kidney transplant offers significant survival and quality-of-life advantages compared with dialysis. But for patients seeking transplant who are highly sensitized, waiting times have traditionally been long and
Daniela Alfere +6 more
doaj +1 more source
Objective: The objective of the study is to assess the graft and patient outcome after desensitization in human leukocyte antigen incompatible kidney transplantation (KT) with positive baseline complement-dependent cytotoxic (CDC) crossmatch and high ...
Vijay Kumar Sinha +6 more
doaj +1 more source
BackgroundThe impact of donor-specific antibodies (DSA) in (highly-) immunized living donor kidney transplant recipients is reported differentially in various patient cohorts.MethodsWe have performed a retrospective analysis of all consecutive HLA ...
T. Tramper +9 more
doaj +1 more source
Therapeutic Plasma Exchange Ameliorates Incompatible Crossmatches
WOS ...
Mehmet Özen +6 more
openaire +3 more sources

